52.7 F
New York
Monday, November 28, 2022

Date:

Share:

Bosch’s Vivalytic platform offering new PCR rapid test for MRSA

Related Articles

ClinicalPURSUIT Offers Free Demonstration to Help Clinical Research Understand Their System and How It Can Help During Clinical Trials

Clayton, MO, November 25, 2022 --(PR.com)-- Clinical trials are expensive to conduct but are also essential in modern medicinal and therapeutic development. There is a...

ClinicalPURSUIT’s Software Offers Interactive Randomization Technology and RTSM to Help Researchers Conduct Flawless Clinical Research

Clayton, MO, November 25, 2022 --(PR.com)-- Clinical trials are crucial to developing modern medicines and therapeutic treatments. These research and trials are expected to be...

ClinicalPURSUIT’s Configurable Dashboards Assists Researchers in Conducting Clinical Research

Clayton, MO, November 25, 2022 --(PR.com)-- Clinical trials are fundamental to the success of modern medicinal and therapeutic development. However, there is a great need...

The Vivalytic test MRSA/SA provides a quick diagnosis of methicillin resistance at the point of care

  • As a real-time PCR rapid test at the point of care (POC), the Vivalytic test MRSA/SA can detect two of the most important pathogens associated with hospital-acquired infections.
  • Differentiation as to whether the bacterial strain is methicillin-resistant or methicillin-sensitive promotes targeted therapy.
  • The result is available in under one hour, which makes the test a useful addition for determining cultures, especially in emergency situations.
  • Unnecessary, costly isolation measures that are stressful for patients can be avoided.

Waiblingen – The new Vivalytic test MRSA/SA for Bosch’s Vivalytic platform is now available. Bosch Healthcare Solutions has once again expanded the test portfolio of this universal PCR system. The Bosch test, developed in cooperation with partner r-biopharm, detects…

Read more…

Popular Articles